Arisaph Pharmaceuticals

Healthcare 📍 Boston, United States 👥 51-200 employees 💰 $10.0M raised 📅 Founded 1999

Arisaph Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for cancer, cardiovascular disease, and diabetes. Its products include dipeptidylpeptidase IV inhibitors, stable GLP-1 agonists, HDL modulators and plaque reducers, and tumor activated pro-soft drugs. Arisaph Pharmaceuticals, In

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

51-200

Total Raised · Venture

$10.0M

Founded

1999

Cloud

Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	🔒 Subscribers only
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$450K – $1M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Arisaph Pharmaceuticals's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Mylan Specialty

201-500 ☁️ AWS

201-500 ☁️ Cloudflare

Park Hotels & Resorts

51-200 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction